Reparixin | m-entrepreneurship.com

Product Name :
Reparixin

Search keywords :
Reparixin

drugId :
null

Target Vo:
C-X-C motif chemokine receptor 1

Target Vo Short Name :
CXCR1

Moa_Name:
C-X-C motif chemokine receptor 2 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Dompe Farmaceutici Spa

Active Company_Name :
Dompé Pharmaceutici Spa

Active Indication_Name:
Pneumonia

In Active Indication_Name:
Rejection of lung transplantation

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Magrolimab manufacturer
Sugemalimab In stock
Proteasome beta 8 Antibody (YA684): Proteasome beta 8 Antibody (YA684) is a non-conjugated and Mouse origined monoclonal antibody about 30 kDa, targeting to Proteasome beta 8 (3G3). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Rat.

Author: Betaine hydrochloride

Related Posts